These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33436028)

  • 21. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers.
    Hicks CW; Selvarajah S; Mathioudakis N; Perler BA; Freischlag JA; Black JH; Abularrage CJ
    J Vasc Surg; 2014 Nov; 60(5):1247-1254.e2. PubMed ID: 24939079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations.
    Sargen MR; Hoffstad O; Margolis DJ
    J Diabetes Complications; 2013; 27(2):128-33. PubMed ID: 23062327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations.
    Ragnarson Tennvall G; Apelqvist J
    Diabetologia; 2001 Nov; 44(11):2077-87. PubMed ID: 11719840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Tale of Two Eras: Mining Big Data from Electronic Health Records to Determine Limb Salvage Rates with Podiatry.
    Schmidt BM; Holmes CM; Ye W; Pop-Busui R
    Curr Diabetes Rev; 2019; 15(6):497-502. PubMed ID: 30332970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidisciplinary clinics reduce treatment costs and improve patient outcomes in diabetic foot disease.
    Joret MO; Osman K; Dean A; Cao C; van der Werf B; Bhamidipaty V
    J Vasc Surg; 2019 Sep; 70(3):806-814. PubMed ID: 30850290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting.
    Apelqvist J; Ragnarson-Tennvall G; Larsson J; Persson U
    Foot Ankle Int; 1995 Jul; 16(7):388-94. PubMed ID: 7550950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes-related major lower limb amputation incidence is strongly related to diabetic foot service provision and improves with enhancement of services: peer review of the South-West of England.
    Paisey RB; Abbott A; Levenson R; Harrington A; Browne D; Moore J; Bamford M; Roe M;
    Diabet Med; 2018 Jan; 35(1):53-62. PubMed ID: 29023974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is diabetic foot care efficacious or cost effective?
    Armstrong DG
    Ostomy Wound Manage; 2001 Apr; 47(4):28-32. PubMed ID: 11890086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experiences and impact of a rural Australian high-risk foot service: A multiple-methods study.
    Tehan PE; Donnelly H; Martin E; Peterson B; Hawke F
    Aust J Rural Health; 2024 Apr; 32(2):286-298. PubMed ID: 38337146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs.
    Hicks CW; Selvarajah S; Mathioudakis N; Sherman RE; Hines KF; Black JH; Abularrage CJ
    Ann Vasc Surg; 2016 May; 33():149-58. PubMed ID: 26907372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost utility of a multi-disciplinary foot protection clinic (MDFPC) in an Irish hospital setting.
    Nason GJ; Strapp H; Kiernan C; Moore K; Gibney J; Feeley TM; Egan B; Tierney S
    Ir J Med Sci; 2013 Mar; 182(1):41-5. PubMed ID: 22528251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost of diabetic foot ulcers and amputations to the National Health Service in England.
    Kerr M; Barron E; Chadwick P; Evans T; Kong WM; Rayman G; Sutton-Smith M; Todd G; Young B; Jeffcoate WJ
    Diabet Med; 2019 Aug; 36(8):995-1002. PubMed ID: 31004370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The financial burden of surgical and endovascular treatment of diabetic foot wounds.
    Joret MO; Dean A; Cao C; Stewart J; Bhamidipaty V
    J Vasc Surg; 2016 Sep; 64(3):648-55. PubMed ID: 27565588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A model to analyse costs and benefit of intensified diabetic foot care in Austria.
    Habacher W; Rakovac I; Görzer E; Haas W; Gfrerer RJ; Wach P; Pieber TR
    J Eval Clin Pract; 2007 Dec; 13(6):906-12. PubMed ID: 18070261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments.
    Redekop WK; Stolk EA; Kok E; Lovas K; Kalo Z; Busschbach JJ
    Diabetes Metab; 2004 Dec; 30(6):549-56. PubMed ID: 15671925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs of deep foot infections in patients with diabetes mellitus.
    Tennvall GR; Apelqvist J; Eneroth M
    Pharmacoeconomics; 2000 Sep; 18(3):225-38. PubMed ID: 11147390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience.
    Van Gils CC; Wheeler LA; Mellstrom M; Brinton EA; Mason S; Wheeler CG
    Diabetes Care; 1999 May; 22(5):678-83. PubMed ID: 10332665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers.
    Rice JB; Desai U; Ristovska L; Cummings AK; Birnbaum HG; Skornicki M; Margolis DJ; Parsons NB
    J Med Econ; 2015; 18(8):586-95. PubMed ID: 25786331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of diabetic foot disease to the National Health Service in England.
    Kerr M; Rayman G; Jeffcoate WJ
    Diabet Med; 2014 Dec; 31(12):1498-504. PubMed ID: 24984759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The diabetic foot. Optimal prevention and treatment can halve the risk of amputation].
    Apelqvist J; Bergqvist D; Eneroth M; Larsson J
    Lakartidningen; 1999 Jan; 96(1-2):37-41. PubMed ID: 9951247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.